Thanks for choosing mmm-online.com Sign up for your FREE account now and join the thousands of other healthcare marketing professionals who rely on us for all the latest industry news and innovative ideas for direct and digital strategy. Simply fill out the fields below.

Keep me logged in Forgot your password?

Please wait...

Please wait...

 Conflict Of Interest

Researchers find schools minting pitch-resistant docs

February 04, 2013

A BMJ study finds that medical school gift bans make doctors less likely to prescribe a new drug. Also of note: consumers think money motivates some doctors' recommendations.
 

CMS releases "Sunshine" final rule: federal preemption, August start date

February 01, 2013

CMS issued its long-delayed final rule for collecting data on industry payments to physicians, ordering data collection to begin in August and asserting that the federal law preempts state laws.
 

GSK's Connelly: We've changed our ways (and please don't imprison execs)

November 05, 2012

GlaxoSmithKline's Dierdre Connelly peeled back the curtain on the company's sales force incentives revamp in a speech to the Pharmaceutical Regulatory and Compliance Congress, and pleaded for recognition that the industry had cleaned up the sketchy practices of the Blockbuster Era.
 

Medtronic defends physician ties IDed in Senate report

October 29, 2012

Medtronic rebuffed Senate Finance Committee charges that the company ghostwrote or influenced journal articles about its InFuse bone-growth product while conspiring to paper over adverse events from the treatment.
 

Docs downgrade results of pharma-funded clinical trials

September 20, 2012

Physicians take pharma-sponsored clinical trials with a grain of salt, a study published in The New England Journal of Medicine has found.
 

Sunshine Act could scare docs away from commercially-supported CME

September 13, 2012

Physicians are reconsidering their participation in industry-sponsored CME, fearful that their inclusion in Sunshine Act databases as having received payments from companies will tarnish their reputations and fuel perceptions of conflicts of interest, a survey has found.
 

Makers of pain pills, advocacy groups at center of Senate probe

May 09, 2012

The Senate Finance Committee is looking to crack down on unnecessary pain prescriptions and is using a money trail to do it.
 

Journal "pharmascolds" skew policy, says study

April 12, 2012

Medical journal coverage of the question of physician-industry relationships is "unbalanced" and may be skewing public policy towards ever-more restrictive safeguards against industry influence.
 

Require disclosure of pharma ties, most docs say

February 14, 2012

The majority of physicians agrees that it's important to disclose to patients any financial relationships with drug and device companies but, research shows, there remains considerable rearguard sentiment to transparency.
 

Despite decline, ghostwriting in papers still common: study

October 25, 2011

Researchers analyzing the prevalence of ghostwriting in leading medical journals over more than a decade saw a decline but found inappropriate authorship remained all too common.
 

One fourth of family medicine residencies "pharma free," says survey

March 25, 2011

Most US family medicine resident programs have limits on drug industry interaction with doctors, and a quarter shun doctor-company contacts altogether, said a survey by Georgetown University Medical Center and the American Medical Student Association.
 

In stepping up COI rules, Yale takes 'rational' approach to industry

September 16, 2010

Yale School of Medicine, which created conflict-of-interest guidelines years ago, has made them binding for physicians in its faculty practice.
 

ACCME: Peer review, plus other provider controls, enable industry employees to present original research in CME

June 29, 2010

Several months' worth of dialogue, at times public and heated, between physician groups like the American Heart Association and the ACCME, has resulted in new guidance from the regulator of continuing medical education: Industry scientists, who had been barred from presenting original product-related research at for-credit talks, may now do so as long as provider controls ensure they have zero control over the content.
 

Physician leaders push back on policy barring industry speakers from talks

June 17, 2010

A policy barring pharmaceutical industry employees from giving continuing medical education talks at meetings has elicited strong opposition from physician leaders.
 

NIH still thinks universities make the best conflict watchdog

May 26, 2010

The nation's biggest funder of biomedical research has proposed several changes to its rules governing when and how investigators should disclose financial interests from industry.
 

Specialty societies' code targets conflicts of interest

April 22, 2010

Medical society journals must ban ghostwritten articles and cannot place ads for drugs next to editorial content discussing those products or their makers under a sweeping ethics code signed by several major medical societies.
 

FDA proposes more openness about advisors' financial ties

April 22, 2010

The FDA announced a proposal to disclose more information about financial interests among its advisory committee members, while the agency's commissioner, Margaret Hamburg, offered some advice of her own, outlining steps for recruiting needed experts who have financial conflicts.
 

In protecting market research, federal exclusion may not always apply

March 25, 2010

Thanks to the work of lobbyists, marketing research-related payments are explicitly excluded from Sunshine legislation enacted Tuesday as part of the healthcare overhaul. But the exclusion may not always apply.
 

New Jersey's tough new conflict regs face uncertain future

December 07, 2009

Conflict-of-interest rules announced by New Jersey's Division of Consumer Affairs last week would seem to have mixed prospects under an incoming Republican administration.
 

Journal editors subject authors to greater scrutiny

October 15, 2009

Researchers submitting manuscripts to many medical journals will have to fill out a more probing disclosure form aimed at exposing potential conflicts of interest.
 

Fewer than 1% of docs sees bias in online CME, survey finds

September 15, 2009

A Medscape-sponsored survey of a million physicians participating in online CME found that fewer than 1% perceived bias, regardless of whether or not it was commercially-supported.
 

Nissen: ACCME should be abolished

July 29, 2009

The Accreditation Council for Continuing Medical Education is a toothless watchdog and should be abolished, said Cleveland Clinic's Dr. Steven Nissen at a Senate Committee on Aging hearing.
 
  

Web Exclusive

Angelina Jolie's fearless but flawed message

Paul Oestreicher, Ph.D. May 17, 2013

Angelina Jolie's story raises important questions about education, outreach and access—but her nod to holistic treatments is less helpful
 

Podcasts

How to engage even the busiest physicians

March 04, 2013

Sponsored by TRUE Health + Wellness. The increasingly demanding schedules of healthcare professionals continue to narrow the window of opportunity for pharma sales teams, and, as a result, marketers are focusing more on non-personal promotion. However, there's a lot more to it than simply bombarding physicians with brand messages, as Anne Stroup, Managing Director at TRUE Health + Wellness, explains to MM&M's James Chase in this special podcast presentation.
 

2013 Hall of Fame Inductees

An entertaining look at the extraordinary lives and careers of the Medical Advertising Hall of Fame's 2013 inductees: Peter Frishauf, Dorothy Philips and David Labson. Clips produced by JUICE Pharma. 

Slideshows

MAHF 2013: Honors Class

A gallery of images from the 2013 Medical Advertising Hall of Fame induction dinner
 
Popular Topics
Acquisition Adherence Advertising Approval Clinical Trial Consumer Corporate Reputation Diabetes DTC Earnings FDA Generic Generic Drugs Health Affairs Marketing & Communications Merck Merger Mobile Obesity Oncology Patent Cliff Patents Patients Regulatory Wellness